- Home
- TARS vs RNG Comparison
TARS vs RNG Comparison
Compare TARS & RNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARS | RNG |
|---|---|---|
| Founded | 2016 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.5B |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | TARS | RNG |
|---|---|---|
| Price | $63.52 | $45.53 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 14 |
| Target Price | ★ $89.00 | $33.58 |
| AVG Volume (30 Days) | 446.1K | ★ 1.3M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.75% |
| EPS Growth | 48.21 | ★ 176.19 |
| EPS | N/A | ★ 0.48 |
| Revenue | $451,360,000.00 | ★ $2,515,142,000.00 |
| Revenue This Year | $56.43 | $5.56 |
| Revenue Next Year | $30.19 | $4.56 |
| P/E Ratio | ★ N/A | $83.65 |
| Revenue Growth | ★ 146.71 | 4.78 |
| 52 Week Low | $38.51 | $23.59 |
| 52 Week High | $85.25 | $43.83 |
Technical Indicators
Market Signals| Indicator | TARS | RNG |
|---|---|---|
| Relative Strength Index (RSI) | 42.83 | 68.00 |
| Support Level | $61.24 | $25.56 |
| Resistance Level | $67.70 | N/A |
| Average True Range (ATR) | 3.19 | 2.05 |
| MACD | -0.40 | 0.30 |
| Stochastic Oscillator | 25.54 | 91.69 |
Price Performance
Historical ComparisonAbout TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.
About RNG RingCentral Inc.
RingCentral is a unified communications as a service, or UCaaS, provider. Its software helps users communicate and collaborate via voice, video, and messaging across all device types and all from one platform. RingCentral helps customers modernize and move from legacy on-premises systems to modern, cloud-based systems. Beyond its core RingCentral MVP solution, RingCentral also offers a cloud-based contact center solution, a stand-alone video meetings solution, and webinars.